Boveri H

Idioma: Español
Referencias bibliográficas: 10
Paginas: 240-242
Archivo PDF: 147.37 Kb.

FRAGMENTO

INTRODUCCIÓN

Las cirugías de trasplantes son la única terapia definitiva disponible para tratar la enfermedad cardíaca, hepática, pulmonar, pancreática o renal, en sus estadios terminales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Egan T et al. Fentanyl phamacokinetics in hemorrhagic shock. Anesthesiology. 1999;91:156-166.

2. Johnson KB et al. Influence of hemorrhagic shock on remifentanil. Anesthesiology. 2001;94:322-332.

3. Shafer SL. Shock values. Anesthesiology. 2004;101:567-568.

4. Takizawa D et al. Changes in apparent systemic clearance of propofol during transplantation of living related donor liver. Br J Anaesth. 2005;95:643-647.

5. Takizawa D et al. Pharmacodynamics of propofol during hemorrhagic shock. Anesthesiology. 2005;102:10681069.

6. Takizawa D et al. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth. 2006;96:179-185.

7. Kurita T et al. The influence of hemorrhagic shock on the electroencephalographic and immobilizing effects of propofol in a swine model. Anesth Analg. 2009;109:398-404.

8. Struys MM et al. Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamics concepts. Br J Anaesth. 2011;107:38-47.

9. Kurita T et al. Influence of haemorrhage on the pseudo-steady-state remifentanil concentration in a swine model: a comparison with propofol and the effect of haemorrhagic shock stage. Br J Anaesth. 2011;107:719-725.

10. Shekar K et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9-18.